Related Experiment Video
Updated: Jul 3, 2026

A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Fall risk, vestibular schwannoma, and anticoagulation therapy
Janet Shelfer1, David Zapala, Larry Lundy
1Mayo Clinic Florida, 4500 San Pablo Rd., Jacksonville, FL 32224, USA. shelfer.janet@mayo.edu
Abstract:
Elderly patients with balance problems are at high risk for falls. When these same patients are also on anticoagulants, the consequences of a fall can be serious. Anticoagulant therapy increases the risk of cerebral hemorrhage. Even mild head trauma can cause a fatal cerebral hemorrhage when anticoagulants are used. However, this risk needs to be weighed against the possibility of spontaneous stroke. The decision to choose anticoagulant therapy can become even more complicated if the patient has an increased risk of falling. A case is presented of an 87-year-old female with balance problems, in part from a small unilateral vestibular schwannoma. She was also receiving Coumadin anticoagulant therapy. When she began to fall, a decision had to be made about the relative risks and benefits of Coumadin therapy. The risk/benefit calculation could change, however, depending on whether her fall risk could be improved. This article presents the diagnostic test results and medical opinions surrounding this case. The importance of assessing patients' overall situation is stressed in planning rehabilitation.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Equilibrium and Balance
Venous Thrombosis I: Introduction
Pulmonary Embolism III: Nursing Management
Aneurysm IV: Nursing Management